NasdaqGS - Nasdaq Real Time Price USD

CVRx, Inc. (CVRX)

4.8100
-2.9700
(-38.12%)
As of 2:33:08 PM EDT. Market Open.

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 12.35M
Earnings -13.77M

Q2'24

Q3'24

Q4'24

Q1'25

-10M
0
10M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

7.00
13.83 Average
4.8100 Current
20.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 3335
Avg. Estimate -0.54-0.51-2.06-1.94
Low Estimate -0.58-0.52-2.08-2.18
High Estimate -0.5-0.5-2.05-1.4
Year Ago EPS -0.65-0.57-2.65-2.06

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 5546
Avg. Estimate 13.32M14.65M55.98M68.31M
Low Estimate 13M13.9M55M58.36M
High Estimate 13.6M15.6M56.5M83.1M
Year Ago Sales 11.81M13.37M51.29M55.98M
Sales Growth (year/est) 12.85%9.56%9.14%22.02%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. -0.55-0.47-0.38-0.57
EPS Actual -0.65-0.57-0.43-0.53
Difference -0.1-0.1-0.050.04
Surprise % -18.80%-21.72%-14.56%7.09%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.54-0.51-2.06-1.94
7 Days Ago -0.55-0.5-2.05-1.8
30 Days Ago -0.55-0.5-2.05-1.8
60 Days Ago -0.51-0.49-2-1.71
90 Days Ago -0.51-0.49-2-1.71

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days 4144
Down Last 30 Days 4144

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
CVRX 16.77%10.52%22.10%6.24%
S&P 500 13.06%3.09%8.02%13.74%

Upgrades & Downgrades

Maintains Piper Sandler: Overweight to Overweight 5/9/2025
Downgrade JP Morgan: Neutral to Underweight 5/9/2025
Maintains Lake Street: Buy to Buy 4/8/2025
Maintains Canaccord Genuity: Buy to Buy 4/8/2025
Maintains Piper Sandler: Overweight to Overweight 2/5/2025
Maintains Canaccord Genuity: Buy to Buy 2/5/2025

Related Tickers